.png){kind=logo}
informative non-academics blog posts coming soon..
Courses section is Coming soon..
Colleges and Universities section is Coming soon..
Under Construction..
Home ❭ Questions ❭ One Liners ❭ Name term that describes a solid of regular shape and the presence of three-dimensional order on the level of atomic dimensions, for a given molecule.
Name term that describes a solid of regular shape and the presence of three-dimensional order on the level of atomic dimensions, for a given molecule.
Pharmaceutics Pharmacist Competitive Exams
Q. Name term that describes a solid of regular shape and the presence of three-dimensional order on the level of atomic dimensions, for a given molecule.
Ans → crystalline
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-3 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-3
Q. An Obstacle such as coating or embedding, which acts as a factor controlling the rate of drug release.
Ans → diffusion barrier
Explanation →
Q. Name a stage in the drying of solids, above which the drying rate is linear, at which the drying rate ceases to be linear, until it reaches the equilibrium moisture content.
Ans → critical moisture content
Explanation →
Q. Formulation in which individual doses of a granulated dosage form are separated
Ans → divided granule
Explanation →
Q. Type of comparative bioavailability study designed in such a way as to take into account differences in bioavailability arising from differences between patients suffering from disease
Ans → crossover study
Explanation →
Q. Powder formulation in which individual doses of a powdered dosage form are separately wrapped
Ans → divided powder
Explanation →
Q. Name term that describes a solid of regular shape and the presence of three-dimensional order on the level of atomic dimensions, for a given molecule.
Ans → crystalline
Explanation →
Q. A Formulated preparation of molecules/drugs that are rarely if ever suitable for administration to patients without additives.
Ans → dosage form
Explanation →
Q. Dosage form in which the active ingredient is insoluble in the carrier; includes aerosols, suspensions, emulsions , and foams
Ans → disperse system
Explanation →
Q. A Biologically active substance, which when biodistributed in the body is expected to modify one or more of its functions.
Ans → drug
Explanation →
Q. Solid preparation that on contact with water breaks apart by the effect of gas evolution, resulting commonly from the reaction of hydrogen carbonate with citric or tartaric acid, in order to facilitate dissolution or dispersion of the active ingredient before ingestion.
Ans → effervescent tablet
Explanation →
Q. Opposite of deliquescence; the drying of a salt solution when the vapour pressure of water in the saturated solution of a substance is greater than the partial pressure of water in the ambient air.
Ans → efflorescence
Explanation →
Q. Name a technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures, typically as a matrix dosage form, in order to change the rate of release.
Ans → embedding
Explanation →
Q. Sweet (often colored) dilute alcohol-based, “hydroalcoholic”, liquid used in the compounding of drugs to be taken by mouth in order to improve palatability.
Ans → elixir
Explanation →
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an upward-directed stream of fluid
Ans → elutriation
Explanation →
Q. Name a substance that loses water to form a lower hydrate or becomes anhydrous spontaneously.
Ans → efflorescent
Explanation →
More one-liners in - Pharmaceutics
Q. Name the study that compares entire genomes, including the complete set of genes, their nucleotide sequence and organization
Ans → Genomics
Explanation →
Q. Condition of being aseptic, or statistically free from living microorganisms and their spores.
Ans → sterility
Explanation →
Q. Different crystalline form of a solvated compound that differ in the identity and/or the stoichiometry of the solvating molecule.
Ans → pseudopolymorph
Explanation →
Q. Dosage form comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.
Ans → multi compartment formulation
Explanation →
Q. A substance that can make a chemical reaction faster but which is not actually needed to produce the reaction nor is used in the reaction.
Ans → catalyst
Explanation →
Q. Adherence of particles into a larger mass due to moisture, static charge, or chemical or mechanical binding
Ans → agglomeration
Explanation →
Q. An infection of the external ear canal, most commonly caused by Pseudomonas aeruginosa; often called swimmer’s ear
Ans → otitis externa
Explanation →
Q. A host in which a parasite goes through some stages of its life cycle before migrating to the definitive host
Ans → intermediate host
Explanation →
Q. Ascorbic acid is not synthesized in man due to lack of the enzyme
Ans → L-Gulonolactone oxidase
Explanation →
Q. The scientist who observed that there exists a relationship between the contents of purines and pyrimidines in DNA structure
Ans → Erwin Chargaff
Explanation →
Q. Close, tight aggregation of colloid particles, emulsion droplets, suspension particles, which are difficult to redisperse.
Ans → coagulation
Explanation →
Q. The process of separation of a racemate into its two enantiomers by means of some chiral agency.
Ans → resolution
Explanation →
Q. reactions which proceed by means of a set of repeating cyclical steps, e.g. the free radical addition of hydrogen bromide to an alkene.
Ans → chain reaction
Explanation →
Q. Type of comparative bioavailability study designed in such a way as to take into account differences in bioavailability arising from differences between patients suffering from disease
Ans → crossover study
Explanation →
Q. A process in which the forward reaction can reach an equilibrium with the reverse reaction.
Ans → reversible process
Explanation →
Q. Substrate level phosphorylation in citric acid cycle is catalysed by the enzyme
Ans → Succinate thiokinase
Explanation →
Q. The oxidation of ferrous (Fe2+) iron to ferric (Fe3+) iron in hemoglobin results in the formation of a compound namely
Ans → Methemoglobin
Explanation →
Q. Name the formation, development, and differentiation of blood cells from pluripotent hematopoietic stem cells
Ans → hematopoiesis
Explanation →
Q. The ability of electrons to "shuffle," or alternate, between bonds, making the molecule extremely stable. The best example of this is benzene.
Ans → Resonance
Explanation →
Q. The lipids that possess both hydrophobic (non -polar) and hydrophilic (polar) groups are known as
Ans → amphipathic
Explanation →
Q. Process that differentiates or separates solid particles according to their size using a meshed or perfo- rated device.
Ans → sieving
Explanation →
Q. Transfer of a drug across a membrane by a transporter (often a protein) constituent of the cytosol membrane.
Ans → carrier-mediated drug transport
Explanation →
Q. Which bond is formed between the negatively charged phosphate groups that holds a lot of potential energy
Ans → high-energy phosphate bond
Explanation →
Q. The following anticoagulant binds with Ca2+ and prevents blood clotting
Ans → Oxalate
Explanation →
Q. Reactions in which an unsaturated system is saturated or part saturated by the addition of a molecule across the multiple bond.
Ans → addition reactions
Explanation →
Q. Movement of a pathogen from one host to another population through physical contact or through droplet transmission
Ans → horizontal direct transmission
Explanation →